Abeona Therapeutics Inc (NASDAQ:ABEO – Get Free Report) was the target of a significant increase in short interest in February. As of February 15th, there was short interest totalling 1,560,000 shares, an increase of 100.4% from the January 31st total of 778,500 shares. Based on an average daily trading volume, of 287,500 shares, the days-to-cover ratio is presently 5.4 days. Currently, 6.7% of the company’s shares are short sold.
Abeona Therapeutics Price Performance
NASDAQ ABEO opened at $7.81 on Friday. The company’s fifty day simple moving average is $5.55 and its 200-day simple moving average is $4.66. Abeona Therapeutics has a 52 week low of $2.24 and a 52 week high of $7.87.
Insider Transactions at Abeona Therapeutics
In other news, Director Mark Alvino sold 7,084 shares of Abeona Therapeutics stock in a transaction dated Wednesday, January 17th. The shares were sold at an average price of $5.11, for a total transaction of $36,199.24. Following the completion of the sale, the director now directly owns 62,816 shares in the company, valued at $320,989.76. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 3.30% of the company’s stock.
Institutional Inflows and Outflows
Analysts Set New Price Targets
Separately, StockNews.com downgraded shares of Abeona Therapeutics from a “hold” rating to a “sell” rating in a report on Monday, February 19th.
Get Our Latest Stock Report on ABEO
Abeona Therapeutics Company Profile
Abeona Therapeutics Inc, a clinical-stage biopharmaceutical company, focuses on developing and delivering gene therapy products for severe and life-threatening rare diseases. The company's lead programs are EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102, which are AAV based gene therapies for Sanfilippo syndrome type A; and ABO-101, an adeno-associated virus (AAV) based gene therapies for Sanfilippo syndrome type B.
Further Reading
- Five stocks we like better than Abeona Therapeutics
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- How to Buy Bitcoin Stock: 3 Easy Ways to Do It
- What Makes a Stock a Good Dividend Stock?
- Snowflake Stock Plunges, Don’t be Fooled, Bargain Alert
- Election Stocks: How Elections Affect the Stock Market
- Block Stock Just Hit the Recovery Rally Button
Receive News & Ratings for Abeona Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abeona Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.